13.03.2017 • News

PMC Biogenix Expands US Fatty Acid Intermediates

(c) Thomas Henderson/Getty Images
(c) Thomas Henderson/Getty Images

PMC Biogenix, a developer and manufacturer of specialty chemicals from renewable resources, has expanded capacity for long chain fatty acid intermediates in Memphis, Tennessee, USA. The company said the project was to support its recent expansion of fatty amide slip agents in South Korea.

Capacity will rise by approximately 50% for both erucic and behenic acids and double for C-20 fatty acids, with production being upgraded to the most current technologies. Last year, PMC Biogenix increased output of fatty amides by 30% at its facility in Gyeonjgu, South Korea, which it acquired in 2014 as part of its purchase of AkzoNobel’s primary amides business.

“Our investment in this new capacity underscores PMC’s strong global position in this segment and our commitment to supporting the growth of the global polyolefins market through expansion and continuous investment to ensure we are employing the state-of-the-art technologies,” said William Hayes, vice president of PMC Biogenix.

Slip agents are used extensively in polyolefins resins and films to overcome their natural tackiness and enable their smooth processing through converting and packaging equipment.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.